8. Screening and Prevention Guidelines for Hematopoietic Cell Transplant Survivors

  1. Bipin N Savani MD
  1. Navneet S Majhail1 and
  2. J Douglas Rizzo2

Published Online: 6 SEP 2013

DOI: 10.1002/9781118473306.ch8

Blood and Marrow Transplantation Long-Term Management: Prevention and Complications

Blood and Marrow Transplantation Long-Term Management: Prevention and Complications

How to Cite

Majhail, N. S. and Rizzo, J. D. (2013) Screening and Prevention Guidelines for Hematopoietic Cell Transplant Survivors, in Blood and Marrow Transplantation Long-Term Management: Prevention and Complications (ed B. N. Savani), John Wiley & Sons, Ltd, Oxford, UK. doi: 10.1002/9781118473306.ch8

Editor Information

  1. Professor of Medicine,Director, Long Term Transplant Clinic, Hematology and Stem Cell Transplantation Section, Vanderbilt University Medical Center, Nashville, TN, USA

Author Information

  1. 1

    National Marrow Donor Program and Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA

  2. 2

    Medical College of Wisconsin and Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA

Publication History

  1. Published Online: 6 SEP 2013
  2. Published Print: 1 OCT 2013

ISBN Information

Print ISBN: 9781118473405

Online ISBN: 9781118473306

SEARCH

Keywords:

  • hematopoietic cell transplantation;
  • long-term survival;
  • late complications;
  • screening;
  • preventive practices

Summary

Hematopoietic cell transplantation (HCT) survivors can be at risk for late complications such as secondary cancers, late infections, and organ toxicity and need continued lifelong surveillance for their screening, early detection, and timely treatment. Guidelines for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT were updated and published in 2012. We summarize the long-term follow-up guidelines in this chapter, discuss ways providers can integrate and utilize them for the care of their patients, and identify areas for research that can inform and increase the utilization of screening and prevention guidelines in clinical practice.